Cipla is pleased to announce the launch of a new Sildenafil generic product to complement its existing range of men’s health medications. The new addition, which is for the treatment of erectile dysfunction (ED), also known as impotence, affords patients a massive saving of 84% versus the original “little blue pill” brand and up to 75% saving compared to other generics in the market.
Erectile dysfunction (ED) is a very common condition, particularly in older men. It is estimated that half of all men between the ages of 40 and 70 will have it to some degree. Unfortunately for many patients suffering from this condition, treatment is costly, as ED is not a chronic condition which is reimbursed for by the medical schemes. Patients are therefore forced to make large out-of-pocket payments to cover the cost of their medication.
ED is often caused by something physical, such as a disease, injury, or side effects from other medications. ED is not all in your head or just a part of aging that you have to accept. It is a real medical condition which can significantly impact a man’s relationships and well-being.
See your GP if you have ED for more than a few weeks. They will assess your general state of health because the condition can be the first sign of more serious health conditions, such as heart disease.
In the interest of our patients, in accordance with South African law and our commitment to expertise, MediHub cannot subscribe to the practice of online diagnosis. Please consult a medical professional for specific medical advice. If you have any major concerns, please see your doctor for an assessment. If you have any cause for concern, your GP will be able to direct you to the appropriate specialists.